Subscribe to our Newsletters !!

    Chemicals

    Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations

    Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit

    UK scientists apply pressure to develop sustainable and affordable catalysis for production of Biorenewable chemicals

    Asynt reports how the Process Intensification Group, within the School of Engineering at Newcastle University, UK is using the MultiCell-PLUS High-Pressure Reactor as part of their program of ongoing research to create a new environmentally friendly generation of catalysts for production of biorenewable chemicals. Many industrial processes rely on catalysts containing expensive precious and metals,